DDX41 and myelodysplastic syndrome: Somatic and germline mutations in DDX41 are present in 0.5 to 4% of adult myelodysplastic syndrome (MDS)/acute myeloid leukemia (AML) cohorts and are considered as oncogenic drivers39.